📝 Kobo Biotech Ltd — results explained
Quarter ended June 2024 (Q1 FY25)
Kobo Biotech Ltd reported revenue of ₹0 crore for the quarter ended June 2024 (Q1 FY25).
The company reported a net loss of ₹1 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.56.
Full year and trailing twelve months
For the full year FY24, Kobo Biotech Ltd posted revenue of ₹0 crore, with a net loss of ₹5 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹5 crore.
Valuation snapshot
At the current price of ₹4.45, 531541 has a market capitalisation of ₹11 crore.
Within the Commodity Chemicals industry, it is the 25th-largest of the 50 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 44.95%, domestic institutional investors (DIIs) 0.00%, public shareholders 55.05% of Kobo Biotech Ltd.